Who is sponsoring NCT03564990?

NCT03564990 is sponsored by Sun Yat-sen University.

What drugs are being tested in NCT03564990?

Interventions in NCT03564990: interactive, multifaceted approach, conventional approach.

What condition does NCT03564990 study?

NCT03564990 studies Congenital Cataract.

Is NCT03564990 still recruiting?

NCT03564990 is currently status unknown. Last updated 21 June 2018.

Last reviewed 2018-06-21 · How we verify

NCT03564990

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Impact of Interactive, Multifaceted Approach Education on Congenital Cataract

Status unknown NA Last updated 21 June 2018

What this trial tests

NA trial testing interactive, multifaceted approach in Congenital Cataract in 80 participants. Status unknown.

Timeline

30 June 2018

Primary endpoint
30 July 2018

30 June 2019

Quick facts

Lead sponsor	Sun Yat-sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	80
Start date	30 June 2018
Primary completion	30 July 2018
Estimated completion	30 June 2019
Sites	1 location across China

Drugs / interventions tested

interactive, multifaceted approach
conventional approach

Conditions studied

Congenital Cataract — all drugs for Congenital Cataract →

Sponsor

Sun Yat-sen University

Who can join

Under 18, any sex, with Congenital Cataract. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the impact of a health education program on parental anxiety, the comprehension-memorization of the information and their satisfaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Cataract

Currently open trials in the same condition.

NCT05136209 — Comparison of Posterior Continuous Curvilinear Capsulorhexis With or Without Anterior Vitrectomy · NA · recruiting
NCT07070037 — Five-Year Visual Function and Refractive Outcomes After Congenital Cataract Surgery · recruiting
NCT03063216 — Shanghai Pediatric Cataract Study · recruiting

Other Sun Yat-sen University trials

Trials by the same sponsor.

NCT07255612 — Bone Marrow Protection, Safety, Efficacy of Trilaciclib and Eribulin in Locally Advanced or Metastatic TNBC(Triple-negat · Phase 2 · not yet recruiting
NCT07371897 — Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial · Phase 3 · not yet recruiting
NCT07489703 — SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLC · Phase 2 · not yet recruiting
NCT07528209 — Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer · Phase 3 · recruiting
NCT07522281 — Evaluation of an Undisturbed Embryo Culture System for Embryo Development in IVF/ICSI Cycles · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03564990 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sun Yat-sen University
Last refreshed: 21 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03564990.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing